Home
Pharma

Labelling Intelligence Platform

Move beyond basic compliance check-boxing. Give your regulatory affairs team the intelligence to defend bold claims, align global messaging, and maintain continuous market readiness.

The platform

The platform, at a glance

Your portfolio, its live findings and the authority sources behind them, on one screen.

Labelex®
Search products, claims or clauses
14 authorities live
Workspace
Portfolio
Global monitoring
Compliance gap analysis
Precedence analysis
Ads & promotional
Library
Authority sources
Audit trail
Portfolio overview
42 products · 21 markets
Open findings
37
across 12 products
High severity
6
need a decision this week
Rule changes
4
in the last 7 days
Inspection ready
92%
of the portfolio
Product
Market
Severity
Latest finding
Cardivastin 20 mg
EU
HIGH
Section 4.4 warning missing against reference product
Cardivastin 20 mg
US
MED
Fair balance below required prominence in detail aid
Nutrivance D3
India
OK
Leaflet agrees with the approved label throughout
Respirex inhaler
UK
MED
Excipient statement differs from the GB template
The platform

One workspace for everything a label touches

Label documents, packaging files, promotional material, authority sources and competitor precedent in one place — kept under continuous active monitoring rather than filed away.

The platform at a glance
One workspace · every market you are registered in
Everything in one place
Label documents & CCDS
Packaging files & patient leaflets
Promotional & ad material
Authority sources & guidance
Competitor label precedent
Labelex®
Labelling intelligence engine
Regulatory rules extracted, your documents structured, and the two continuously compared.
Intelligence you act on
Global label & claim monitoring
Compliance gap analysis
Competitive & precedence analysis
Ads & commercial alignment
Each output carries the clause, the source and the date it was read.
Four areas

The day-to-day work, and the questions above it

Two of these clear your queue. Two of them change what you put on the label in the first place.

Global label & claim monitoring

Authority sources, reference products and your own portfolio watched continuously. Changes arrive as structured rules with the affected labels already identified.

Reference product and safety label changes
Guidance and template revisions per market
Impact routed to the products it touches

Compliance gap analysis

Label documents, packaging files and leaflets checked against each market’s requirements and against each other — for meaning, not string match.

CCDS to local label, label to leaflet
Artwork against the approved document
Translations checked for regulatory meaning

Competitive & precedence analysis

What has already been approved, and to whom. The evidence for writing a stronger claim — or the reason one was refused.

Approved claim wording across comparators
Safety information precedent by market
Where your label is more conservative than it needs to be

Ads & commercial material alignment

Promotional material read against the approved label and the local code — including the impression it leaves as a whole, not just the phrases in it.

Claim traced back to approved label text
Fair balance and required safety statements
Overall perception judgment, market by market
In your own tools

Intelligence delivered right into your playground

Agents work inside the document your team already drafts in. Every suggestion carries the clause it came from, and you decide whether to take it.

Microsoft Word
CCDS_Cardivastin_20mg_v7.docx
Labelex® add-in active
FileHomeInsertReviewLabelex
5.1 Pharmacodynamic properties

Cardivastin is a selective, competitive inhibitor of HMG-CoA reductase.

In a randomized, double-blind placebo-controlled study, Cardivastin demonstrated a highly significant reduction in the risk of major cardiovascular events.

The treatment effect was consistent across all predefined subgroups, including patients with a history of type 2 diabetes.

Agent findings
3 in section
REVISEEMA QRD §5.1
Subjective qualifiers like “highly” are frequently rejected in recent EMA reviews. Suggested wording: “demonstrated a statistically significant reduction”.
AcceptDismiss
OPPORTUNITY5 comparator labels
All 5 reference competitors cite exact Relative Risk Reduction (RRR) percentages here. Adding your trial’s 32% RRR figure strengthens commercial positioning.
MARKET CONFLICTUS FDA Alignment
US PI restricts efficacy claims for the ‘type 2 diabetes’ subgroup without primary endpoint data. Keeping this creates a downstream compliance risk for US distribution.
How it works

Four stages, running on a loop

Nothing waits for a quarterly review. The cycle runs continuously and surfaces only what changed.

01

Bring it together

Label files, promotional material, and the authority sources that govern them.

02

Structure the rules

Regulations and guidance become atomic, checkable rules per market.

03

Compare and judge

Agents assess gaps, precedent and perception, and cite what they relied on.

04

Decide and record

Your reviewer accepts or overrules. The decision, and its reasoning, is logged.

Stage 04 feeds back into stage 01 — recorded decisions become precedent for the next assessment.
Built for regulated review

Every finding is defensible in a room full of auditors

Deterministic orchestration, documented decision logic and source-traceable lineage — the output is evidence, not an opinion.

How our AI works

Reproducible runs

Consistent, testable and validatable results on the same inputs.

Full audit trails

Output logs and documented evidence of conformity for every assessment.

Human decision points

Agents prepare the assessment; your regulatory reviewer still signs it.

Fits your stack

Runs as SaaS or as agents over MCP, alongside your DMS, RIM and QMS.

14
Authorities monitored

Authority sources, reference products and your own portfolio watched continuously. Changes arrive as structured rules with the affected labels already identified.

Test your most complex global label

Send us a core label document and its local packaging files. We’ll run a live gap analysis to show you exactly how the engine validates claims, spots precedence, and builds a defensible audit trail.